RxDoctor Payments DataLook up a doctor →

Erica Stockwell, DO

Obstetrics & Gynecology · Celebration, FLNPI 1750680310

Payments from drug & device makers

$337,522in general payments, 2019–2025

Across 421 payments — averaging $801.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Applied Medical Resources Corporation$169K
  • Momentis Surgical Inc.$57K
  • Intuitive Surgical$35K
  • Distalmotion US$24K
  • Astellas Pharma US Inc$21K
  • Astellas Pharma Global Development$9K
  • plus $22K from 29 others

What the payments were for

  • Consulting fees$64,17620%
  • Speaking & faculty fees$173,42654%
  • Travel & lodging$45,25414%
  • Food & beverage$18,5186%
  • Education$19,5366%
  • Gifts$140%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$337,522 in reported general payments places this provider in the 95th percentile of 2,438 obstetrics & gynecology providers in Florida.

See all obstetrics & gynecology providers in Florida

Medicare billing

Part B allowed, 2024
$41,606
Medicare patients
124
Services billed
244

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron22$16,074
Estradiol99$6,024
PremarinEstrogens, Conjugated11$4,805
ValacyclovirValacyclovir Hcl11$854
Fluconazole42$255
Clobetasol Propionate16$236
Oxybutynin Chloride16$220
Metronidazole12$211
Paroxetine Hcl13$206
Solifenacin Succinate14$197
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen12$61

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$20,650$16,07422 claims
PfizerPremarin$165$4,80511 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,438 obstetrics & gynecology providers in Florida.

Other obstetrics & gynecology in Celebration

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →